First #cardiooncology meeting between Institut Jules Bordet Instituut and @Erasme Hospital @HUB Ruben Casado Arroyo Antoine Bondue casalino giulia @AhmadAwada @SergeMottte @AudreyVervacke International Cardio-Oncology Society European Society of Cardiology OncoAlert

#ESC2023 Guidelines for the management of #cardiomyopathies In this guideline, is proposed the new term non-dilated left ventricular cardiomyopathy (NDLVC) 👇 more details in the thread Work for the weekend academic.oup.com/eurheartj/arti…

Very exciting data at #esc #session on genes and gene editing in heart failure! A quick but very efficient look into the (close) future! 🙏#escgenomics @CSHeartResearch Andreas Zeiher Silvia Priori @laurazelarayan2 Mauro Giacca

Breaking news #ESCCongress - ATTRibute-CM TRIAL: Acoramidis improves outcomes in patients with ATTR-CM compared with placebo Victoria Delgado Dr Roxana Mehran MIЯVΛƬ #IC David Duncker C. Michael Gibson MD chief Henry Han Jozine ter Maaten @mewton_nathan Maggie Simpson Amina

Great summary of ATTRibute-CM results. Exciting (and also complex) times ahead!!

!!#ESC Cardio Genomics 2023: registration & call for abstracts now open!! #ESCgenomics #MedTwitter 👉Join us in Naples, 21 – 22 October 2023. ☝️Open to every HCP in link with genomic medicine, and researchers esc365.escardio.org/event/1089

Upcoming European Society of Cardiology webinars discussing 🆕 #cardiomyopathies guidelines with members of the Task Force! 🆓 registration for #ESC professional members! Register now esc365.escardio.org/event/1062?utm… Juan Pablo Kaski Pablo Garcia-Pavia Alex Protonotarios Ruxandra Jurcut Elena Arbelo Silvia Castelletti Massimo Imazio

Don’t miss this great #ESC #Escgenomics Focus on cardiomyopathies 👉 escardio.org/Education/ESC-… 🙏👏Elena Arbelo Juan Pablo Kaski Sara Moscatelli Ronen Beeri & Gabrielle Norrish

Mavacamten, a myosin inhibitor, is the first disease-specific treatment for obstructive hypertrophic cardiomyopathy. Read more in #EHJ. doi.org/10.1093/eurhea… #hypertrophic #cardiomyopathy #myosin #cardiotwitter European Society of Cardiology Journals European Society of Cardiology

Advocating the need for more clinical and basic #research to combat #CardiovascularDisease at the #VoteHealth2024 exhibit at the European Parlement European Society of Cardiology European Society of Cardiology Advocacy European Alliance for Cardiovascular Health (EACH) #cardiotwitter #CardiovascularResearch #CVD ESC President

This month we are returning with another heart muscle talks session! We are looking forward to Roddy Walsh 🇪🇺 🇺🇦 presenting on one of the most interesting topics in the field! register here 👉 ucl.zoom.us/webinar/regist…

Cardiomyopathies in children and adolescents: aetiology, management, and outcomes in the European Society of Cardiology EURObservational Research Programme Cardiomyopathy and Myocarditis Registry. Read more in #EHJ European Society of Cardiology European Society of Cardiology Journals #CardioTwitter academic.oup.com/eurheartj/adva…

CardioGenomics 2024, the meeting of the ESC Council on Cardiovascular Genomics. See you there! European Society of Cardiology Antoine Bondue . esc365.escardio.org/event/1652

Unmissable for the passionates!

State-of-the-art review on genetics of hypertrophic cardiomyopathy (including some possible future applications) - great to see our latest just published EHJ Editor-in-Chief European Society of Cardiology Journals Carolyn Ho UCL Institute of Cardiovascular Science Barts Health academic.oup.com/eurheartj/arti…

Election results out for Council on Cardiovascular Genomics 2024 - 2026 escardio.org/Councils/Counc… Glad to contribute as a nucleus member for two more years! 🧬 don’t forget the first onsite Conference organised by the Council #CardioGenomics2024 abstracts esc365.escardio.org/event/1652 👇

Only two days left to save on registration for the Cardio Genomics Conference 2024 happening on December 6-7 in Antwerp, Belgium. Don't miss out on this opportunity to expand your expertise in the field of cardiovascular genomic medicine and connect with peers from around the

Full house for the first European Society of Cardiology Cardio Genomics Conference in Antwerp. Great programme covering CV Genomics in 360 degrees

Brilliant state-of-the-art review about ATTR treatments by Fernando Domínguez at the ESC Cardiogenomics conference Sección Cardiopatías Familiares y Genética CV SEC

We analysed mitochondrial variation in cardiomyopathy patients from 100K genomes project and found the HCM causing m.4300A>G in 0.6% of (previously) genotype-"negative" HCM patients humgenomics.biomedcentral.com/articles/10.11… - shall we include it in the testing panels? Robert Pitceathly Will Macken